Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors
US12410166B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2022 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Sep 23, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention belongs to the medical field, and relates to novel β-lactamase inhibitors, for the treatment of bacterial infections in combination with β-lactam antibiotics, including infection caused by drug resistant organisms and especially multi-drug resistant organisms. The present invention includes compounds according to formula (I): or pharmaceutically acceptable salts thereof, wherein M and R are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.